COMPANY
Navrogen
Our proprietary Block-Removed Immunoglobulin Technology (BRITE) and screening platforms enable us to engineer antibodies to be refractory or antagonist to the immunosuppression mediated by the HIO factors. From company website Source · Oct 13, 2026